Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy
Clinical trial NCT06722950 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06722950
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.